NSE: SHREECEM | BSE: 500387

Expensive Star

Download real time

30540.00 -165.00 (-0.54%)

New 52W High in past week

27,173 NSE+BSE Volume

NSE 25 Apr, 2025 3:50 PM (IST)

110,190.5

Market Cap

High in industry

0.7

Beta 1Year

Very Low volatility

Shree Cements Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for SHREECEM, BSE:500387 Shree Cements Ltd.

Shree Cements Ltd.

09 Aug 2024

30540.00

-0.54%

Weaker realization and higher opex outweigh volume growth

Accumulate: Shree Cements Ltd.

Recommendation Target

KRChoksey

Shree Cement’s Q1FY25 result missed our projections despite revenue in line with our estimates.
Despite falling cement prices, revenue increased 1.8% YoY (-5.1% QoQ) to INR 51,240 Mn led by strong volume growth.

Shree Cements Ltd. is trading above all available SMAs

Shree Cements Ltd.

08 Aug 2024

30540.00

-0.54%

Result Update:Shree Cement

Hold: Shree Cements Ltd.

Recommendation Target

Axis Direct

We change our rating from BUY to HOLD

Number of FII/FPI investors increased from 532 to 547 in Mar 2025 qtr.

Shree Cements Ltd.

08 Aug 2024

30540.00

-0.54%

Shree Cement

Hold: Shree Cements Ltd.

Target

ICICI Direct

Shree Cements Ltd. has gained 25.32% in the last 1 Year

Shree Cements Ltd.

08 Aug 2024

30540.00

-0.54%

Volume focus singes margin

Hold: Shree Cements Ltd.

Target

ICICI Securities Limited

Shree Cement’s (SRCM) volume focus in Q1FY25 was exceptional given it stood flat QoQ (up 8% YoY) as against 5-20% drop reported by industry majors.

Shree Cements Ltd. is trading above all available SMAs

Shree Cements Ltd.

07 Aug 2024

30540.00

-0.54%

Subdued performance as geo-mix change hurts

Neutral: Shree Cements Ltd.

Target

Motilal Oswal

Shree Cement (SRCM)’s 1QFY25 EBITDA was significantly below our estimate, primarily due to a lower-than-estimated realization (6% miss).

Number of MF schemes increased from 24 to 30 in Mar 2025 qtr.

Shree Cements Ltd.

07 Aug 2024

30540.00

-0.54%

Operationally weak Q1; Retain Buy

Buy: Shree Cements Ltd.

Target

Sharekhan

Standalone revenues marginally lagged estimates at Rs. 4835 crore (down 2.7% y-o-y) as lower than
estimated realisations (down 10% y-o-y, on higher sales in the Eastern region.

Number of FII/FPI investors increased from 532 to 547 in Mar 2025 qtr.

Shree Cements Ltd.

23 May 2024

30540.00

-0.54%

First Light | JK Cement, RBI Dividend, Shree Cement, Bandhan Bank, Eris Lifesciences, Greenply Industries

Hold: Shree Cements Ltd.

Target

BOB Capital Markets Ltd.

JKCE: Focused on growth; earnings intact; upgrade to BUY. RBI Dividend: Record high. SRCM: Cost savings key driver of performance; valuations pricey. BANDHAN: In line with recovery plan. ERIS: Strong revenue growth; integration ongoing. MTLM: Misses estimate on weak plywood margin; upbeat outlook.

Number of FII/FPI investors increased from 532 to 547 in Mar 2025 qtr.

Shree Cements Ltd.

21 May 2024

30540.00

-0.54%

BP Equities Q4FY24 Result Update Shree Cement Ltd

Results Update: Shree Cements Ltd.

BP Wealth

Shree Cements Ltd. is trading above all available SMAs

Shree Cements Ltd.

21 May 2024

30540.00

-0.54%

High-capacity expansion in play; operating leverage driving margin expansion

Buy: Shree Cements Ltd.

Recommendation Target

KRChoksey

Shree Cement reported better-than-expected numbers, which beat estimates across the board.
Revenue increased 6.5% YoY to INR 54,328 Mn due to strong volume growth despite pressure on cement prices.